These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19633901)

  • 1. Capping it off.
    Strauss HW
    J Nucl Cardiol; 2009; 16(5):686-8. PubMed ID: 19633901
    [No Abstract]   [Full Text] [Related]  

  • 2. Dual molecular imaging for targeting metalloproteinase activity and apoptosis in atherosclerosis: molecular imaging facilitates understanding of pathogenesis.
    Haider N; Hartung D; Fujimoto S; Petrov A; Kolodgie FD; Virmani R; Ohshima S; Liu H; Zhou J; Fujimoto A; Tahara A; Hofstra L; Narula N; Reutelingsperger C; Narula J
    J Nucl Cardiol; 2009; 16(5):753-62. PubMed ID: 19662466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted molecular imaging in oncology.
    Yang DJ; Kim EE; Inoue T
    Ann Nucl Med; 2006 Jan; 20(1):1-11. PubMed ID: 16485568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Imaging Probes Based on Matrix Metalloproteinase Inhibitors (MMPIs).
    Rangasamy L; Geronimo BD; Ortín I; Coderch C; Zapico JM; Ramos A; de Pascual-Teresa B
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31426440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of matrix metalloproteinase activation for noninvasive detection of vulnerable atherosclerotic lesions.
    Hartung D; Schäfers M; Fujimoto S; Levkau B; Narula N; Kopka K; Virmani R; Reutelingsperger C; Hofstra L; Kolodgie FD; Petrov A; Narula J
    Eur J Nucl Med Mol Imaging; 2007 Jun; 34 Suppl 1():S1-8. PubMed ID: 17497106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPET: sustainable, powerful, effective, timely in vivo molecular imaging.
    Lucignani G
    Q J Nucl Med Mol Imaging; 2005 Jun; 49(2):117-20. PubMed ID: 16010249
    [No Abstract]   [Full Text] [Related]  

  • 7. Folate receptor–targeted single-photon emission computed tomography/computed tomography to detect activated macrophages in atherosclerosis: can it distinguish vulnerable from stable atherosclerotic plaques?
    Winkel LC; Groen HC; van Thiel BS; Müller C; van der Steen AF; Wentzel JJ; de Jong M; Van der Heiden K
    Mol Imaging; 2014; 13():. PubMed ID: 24757762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular imaging of atherosclerotic plaques targeted to oxidized LDL receptor LOX-1 by SPECT/CT and magnetic resonance.
    Li D; Patel AR; Klibanov AL; Kramer CM; Ruiz M; Kang BY; Mehta JL; Beller GA; Glover DK; Meyer CH
    Circ Cardiovasc Imaging; 2010 Jul; 3(4):464-72. PubMed ID: 20442371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of Molecular Probes for Live Imaging of Cancer and Infectious Diseases].
    Fuchigami T
    Yakugaku Zasshi; 2019; 139(12):1531-1538. PubMed ID: 31787640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiopharmaceutical tracers for cardiac imaging.
    Manabe O; Kikuchi T; Scholte AJHA; El Mahdiui M; Nishii R; Zhang MR; Suzuki E; Yoshinaga K
    J Nucl Cardiol; 2018 Aug; 25(4):1204-1236. PubMed ID: 29196910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [SPECT radiopharmaceuticals -- novelties and new possibilities].
    Balogh L; Polyák A; Pöstényi Z; Haász V; Dabasi G; Jóba R; Bús K; Jánoki G; Thuróczy J; Zámbó K; Garai I; Környei J; Jánoki G
    Magy Onkol; 2014 Dec; 58(4):239-44. PubMed ID: 25517441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of matrix metalloproteinases on atherosclerosis.
    Lin J; Kakkar V; Lu X
    Curr Drug Targets; 2014 Apr; 15(4):442-53. PubMed ID: 24517161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tracer development and hybrid imaging.
    Yang DJ; Kim EE
    Eur J Nucl Med Mol Imaging; 2005 Sep; 32(9):1001-2. PubMed ID: 16086160
    [No Abstract]   [Full Text] [Related]  

  • 14. Letter from the editors: positron emission tomography radiopharmaceuticals-current status.
    Freeman LM; Blaufox MD
    Semin Nucl Med; 2011 Jul; 41(4):243. PubMed ID: 21624558
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiovascular molecular imaging: where art thou?
    Beller GA
    J Nucl Cardiol; 2008; 15(5):611-2. PubMed ID: 18761261
    [No Abstract]   [Full Text] [Related]  

  • 16. Atherosclerosis and matrix metalloproteinases: experimental molecular MR imaging in vivo.
    Amirbekian V; Aguinaldo JG; Amirbekian S; Hyafil F; Vucic E; Sirol M; Weinreb DB; Le Greneur S; Lancelot E; Corot C; Fisher EA; Galis ZS; Fayad ZA
    Radiology; 2009 May; 251(2):429-38. PubMed ID: 19224894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-FDG imaging of atherosclerosis: will imaging of MMPs assess plaque vulnerability?
    Hermann S; Starsichova A; Waschkau B; Kuhlmann M; Wenning C; Schober O; Schäfers M
    J Nucl Cardiol; 2012 Jun; 19(3):609-17. PubMed ID: 22477642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo examination of 111In-bis-5HT-DTPA to target myeloperoxidase in atherosclerotic ApoE knockout mice.
    Wu MC; Ho HI; Lee TW; Wu HL; Lo JM
    J Drug Target; 2012 Aug; 20(7):605-14. PubMed ID: 22738345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinases in pro-atherosclerotic arterial remodeling.
    Myasoedova VA; Chistiakov DA; Grechko AV; Orekhov AN
    J Mol Cell Cardiol; 2018 Oct; 123():159-167. PubMed ID: 30172754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging reporter genes for cell tracking with PET and SPECT.
    Acton PD; Zhou R
    Q J Nucl Med Mol Imaging; 2005 Dec; 49(4):349-60. PubMed ID: 16407818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.